DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.
about
EMT in Breast Carcinoma-A ReviewMiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.The Function of V-ATPases in CancerBLOS2 negatively regulates Notch signaling during neural and hematopoietic stem and progenitor cell development.
P2860
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@ast
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@en
type
label
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@ast
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@en
prefLabel
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@ast
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@en
P2093
P2860
P356
P1433
P1476
DMXL2 drives epithelial to mes ...... hrough Notch hyper-activation.
@en
P2093
Darren K Patten
Giancarlo Pruneri
Jennifer H Steel
Laura Woodley
Monica Faronato
Naina Patel
R Charles Coombes
Sami Shousha
Van T M Nguyen
Ylenia Lombardo
P2860
P304
22467-22479
P356
10.18632/ONCOTARGET.4164
P407
P50
P577
2015-06-04T00:00:00Z